Denmark's Novo Nordisk To Double R&D Workforce In China
This article was originally published in PharmAsia News
Executive Summary
The Danish healthcare company says it plans to increase the workforce in its Beijing research and development center from 100 to 200 by 2015, aimed primarily at staffing a new Diabetes Research Unit